<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04145024</url>
  </required_header>
  <id_info>
    <org_study_id>2001</org_study_id>
    <nct_id>NCT04145024</nct_id>
  </id_info>
  <brief_title>Giessen Pulmonary Hypertension Registry and Biobank</brief_title>
  <official_title>Giessen Pulmonary Hypertension Registry and Biobank</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Giessen Pulmonary Hypertension registry and biobank
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Long-term transplant-free survival and its determinants will be investigated in patients with
      Pulmonary Hypertension (diagnosed by right heart catheterization) within a prospective
      registry at a single referral center in Giessen, Germany.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1993</start_date>
  <completion_date type="Anticipated">January 15, 2036</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2035</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>20 Years</target_duration>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>Up to 20 years after enrollment</time_frame>
    <description>Transplant-free survival of PH patients</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Pulmonary arterial hypertension</arm_group_label>
    <description>Group 1 PH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulmonary hypertension due to left heart disease</arm_group_label>
    <description>Group 2 PH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pulmonary hypertension due to lung disease</arm_group_label>
    <description>Group 3 PH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic thromboembolic pulmonary hypertension</arm_group_label>
    <description>Group 4 PH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Miscellaneous</arm_group_label>
    <description>Group 5 PH</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exclusion PH</arm_group_label>
    <description>Patient with invasively excluded PH</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Study population includes patients referred to our tertial PH expert center in Giessen with
        suspected PH.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Right heart catheterization for PH diagnosis in Giessen

        Exclusion Criteria:

          -  informed consent missing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Henning Gall, MD, PhD</last_name>
    <phone>0641/985-57030</phone>
    <phone_ext>57030</phone_ext>
    <email>henning.gall@innere.med.uni-giessen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Intermal Medicine - Universities of Giessen and Marburg Lung Center</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henning Gall, MD, PhD</last_name>
      <phone>0641/985-57030</phone>
      <email>henning.gall@innere.med.uni-giessen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Gall H, Felix JF, Schneck FK, Milger K, Sommer N, Voswinckel R, Franco OH, Hofman A, Schermuly RT, Weissmann N, Grimminger F, Seeger W, Ghofrani HA. The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups. J Heart Lung Transplant. 2017 Sep;36(9):957-967. doi: 10.1016/j.healun.2017.02.016. Epub 2017 Feb 17.</citation>
    <PMID>28302503</PMID>
  </results_reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 28, 2019</study_first_submitted>
  <study_first_submitted_qc>October 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>October 28, 2019</last_update_submitted>
  <last_update_submitted_qc>October 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

